Search in:

Cancer Management and Research Volume 11, 2019 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Original Research

ADAR1 may be involved in the proliferation of acute myeloid leukemia cells via regulation of the Wnt pathway

Han XiaoDepartment of Hematology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, People’s Republic of China

Qian ChengDepartment of Hematology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, People’s Republic of China

Xinyu WuDepartment of Hematology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, People’s Republic of China

Yishu TangDepartment of Hematology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, People’s Republic of China

Jing LiuDepartment of Hematology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, People’s Republic of China

Xin LiDepartment of Hematology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, People’s Republic of ChinaCorrespondence[email protected] [email protected]

Pages 8547-8555 | Published online: 20 Sep 2019

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (13)

Menghuan Yang, Jun Jiang, Ruimin Ren, Ning Gao, Jun He & Yuebo Zhang. (2024) Role of ADAR1 on Proliferation and Differentiation in Porcine Preadipocytes. Animals 14:8, pages 1201.
Crossref

Alberto Quattrocchi, Luca Vincenzo Cappelli, Giovanna De Simone, Elisabetta De Marinis, Martina Gentile, Tecla Gasperi, Alessandro Pulsoni, Paolo Ascenzi & Clara Nervi. (2023) Biomarkers in acute myeloid leukemia: From state of the art in risk classification to future challenges of RNA editing as disease predictor and therapy target. Aspects of Molecular Medicine 2, pages 100023.
Crossref

Honghong Wang, Lina Yang, Rui Liu, Haiyan He, Miao Zhang & Yuanyi Xu. (2023) ADAR1 affects gastric cancer cell metastasis and reverses cisplatin resistance through AZIN1. Anti-Cancer Drugs 34:10, pages 1132-1145.
Crossref

Mansi Cai, Xiaoping Liu, Ailing Luo, Xu Yang, Yaping Yan, Shanshan Liu, Xueliang Wang, Ziyan Luo, Xuedong Wu, Ke Huang, Lihua Yang, Hua Jiang, Ling Xu & Xiaodan Liu. (2023) ADAR1 polymorphisms contribute to increased susceptibility in pediatric acute lymphoblastic leukemia. Annals of Hematology 102:9, pages 2483-2492.
Crossref

Di Lu, Jianxi Lu, Qiuli Liu & Qi Zhang. (2023) Emerging role of the RNA-editing enzyme ADAR1 in stem cell fate and function. Biomarker Research 11:1.
Crossref

Vanessa S. Morris, Hanya Ghazi, Daniel M. Fletcher & Barbara-ann Guinn. (2023) A Direct Comparison, and Prioritisation, of the Immunotherapeutic Targets Expressed by Adult and Paediatric Acute Myeloid Leukaemia Cells: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences 24:11, pages 9667.
Crossref

Alexis Southwell, M. Neal Guentzel & Rishein Gupta. 2023. RNA Structure and Function. RNA Structure and Function 421 439 .

Tiffany M. Tran & Dinesh S. Rao. (2022) RNA binding proteins in MLL-rearranged leukemia. Experimental Hematology & Oncology 11:1.
Crossref

Claudia Garcia-Gonzalez, Christoph DieterichGiovanni Maroli, Marion Wiesnet, Astrid WietelmannXiang LiXuejun Yuan, Johannes Graumann, Konstantinos Stellos, Thomas KubinAndre SchneiderThomas Braun. (2022) ADAR1 Prevents Autoinflammatory Processes in the Heart Mediated by IRF7. Circulation Research 131:7, pages 580-597.
Crossref

Benigno C. Valdez, David Murray, Bin Yuan, Yago Nieto, Uday Popat & Borje S. Andersson. (2022) ABT199/venetoclax potentiates the cytotoxicity of alkylating agents and fludarabine in acute myeloid leukemia cells. Oncotarget 13:1, pages 319-330.
Crossref

Xiang-Yu Ma, Liuya Wei, Zining Lei, Yanglu Chen, Zhiyong Ding & Zhe-Sheng Chen. (2021) Recent progress on targeting leukemia stem cells. Drug Discovery Today 26:8, pages 1904-1913.
Crossref

Irina A. Elcheva & Vladimir S. Spiegelman. (2020) Targeting RNA-binding proteins in acute and chronic leukemia. Leukemia 35:2, pages 360-376.
Crossref

Margalida Rosselló-Tortella, Gerardo Ferrer & Manel Esteller. (2020) Epitranscriptomics in Hematopoiesis and Hematologic Malignancies. Blood Cancer Discovery 1:1, pages 26-31.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

ADAR1 may be involved in the proliferation of acute myeloid leukemia cells via regulation of the Wnt pathway

Articles from other publishers (13)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

ADAR1 may be involved in the proliferation of acute myeloid leukemia cells via regulation of the Wnt pathway

Citations (13)

Articles from other publishers (13)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date